6612 奈米醫材歷年利潤比率
| 年度/季別 | 毛利率 | 營業利益率 | 稅前淨利率 | 稅後淨利率 |
|---|
| 2025Q2 | 59.57% | 12.22% | -4.88% | -9.93% |
| 2025Q1 | 57.88% | 17.09% | 17.21% | 12.41% |
| 2024Q4 | 67.27% | 14.62% | 18.87% | 6.20% |
| 2024Q3 | 62.20% | 12.35% | 18.39% | 9.82% |
| 2024Q2 | 73.40% | 11.06% | 16.49% | -0.01% |
| 2024Q1 | 81.58% | 20.81% | 23.71% | 8.30% |
| 2023Q4 | 74.64% | 1.73% | -6.10% | -13.38% |
| 2023Q3 | 81.55% | 22.60% | 27.77% | 17.74% |
| 2023Q2 | 81.54% | 24.89% | 29.42% | 21.55% |
| 2023Q1 | 80.41% | 20.72% | 20.87% | 13.95% |
| 2022Q4 | 76.60% | 12.30% | 16.22% | 12.63% |
| 2022Q3 | 88.89% | 31.83% | 38.57% | 33.81% |
| 2022Q2 | 76.12% | 24.32% | 27.97% | 19.50% |
| 2022Q1 | 84.88% | 30.13% | 29.83% | 20.57% |
| 2021Q4 | 82.50% | 25.99% | 25.02% | 17.82% |
| 2021Q3 | 82.19% | 25.97% | 19.84% | 12.50% |
| 2021Q2 | 79.83% | 21.24% | 17.26% | 3.58% |
| 2021Q1 | 83.41% | 14.12% | 9.89% | 1.33% |
| 2020Q4 | 83.74% | 13.75% | 10.17% | -7.77% |
| 2020Q3 | 78.14% | 23.19% | 24.32% | 18.69% |
| 2020Q2 | 81.69% | 19.28% | 13.63% | 3.31% |